PDF herunterladen
Exp Clin Endocrinol Diabetes 2015; 123(02): 126-131
DOI: 10.1055/s-0034-1390422
Article
© Georg Thieme Verlag KG Stuttgart · New York

Osteoblast Proliferation is Enhanced upon the Insulin Receptor Substrate 1 Overexpression via PI3K Signaling Leading to Down-regulation of NFκB and BAX Pathway

H. Ma
1   Department of Endocrinology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
2   Key Biomechanical Laboratory of Orthopedics, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
,
JX. Ma
1   Department of Endocrinology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
,
P. Xue
1   Department of Endocrinology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
,
Y. Gao
1   Department of Endocrinology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
,
YK. Li
1   Department of Endocrinology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
2   Key Biomechanical Laboratory of Orthopedics, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 26. Juli 2014
first decision 01. September 2014

accepted 10. September 2014

Publikationsdatum:
05. November 2014 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

The insulin receptor substrate 1 (IRS1) promotes bone formation via osteoblast proliferation mediated by PI3K/Akt signaling. A reduction in NFκB activity in osteoblasts results in an increase in bone formation. The NFκB signaling pathway leads to increased expression of BAX, which contributes to osteoblast apoptosis. The purpose of this study was to investigate the expression of recombinant plasmid enhanced green fluorescent protein-N1 (pEGFP-N1) that transferred IRS1 gene into osteoblasts in vitro and evaluate the effects of IRS1 overexpression on NFκBp65 and on BAX. Osteoblasts were transfected with pEGFP-N1 or pEGFP-N1 encoding wild-type IRS1 (pEGFP-N1-IRS1). Cell cycle analysis was performed using flow cytometry. The expression levels of NFκBp65 and BAX were measured by Western blotting. Our results revealed that overexpression of IRS1 stimulated osteoblast proliferation, as evidenced by an increase in the number of cells in the S phase compared to controls. IRS1 overexpression in osteoblasts activated the PI3K/Akt pathway, and inhibited expression of NFκBp65 and BAX. When osteoblasts transfected with pEGFP-N1-IRS1 were exposed to a PI3K inhibitor (LY294002), the effects of IRS1 overexpression were reversed. On the basis of our study, it seems that osteoblasts proliferated upon IRS1 overexpression due to inhibition of the NFκB pathway and downregulation of BAX through PI3K/Akt signaling.

Key words

insulin receptor substrate 1 - PI3K signaling - osteoblast proliferation - NFκBp65 - BAX
 

  • References

  • 1 Thrailkill KM, Lumpkin Jr CK, Bunn RC et al. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005; 289 E735-E745. Epub 2005/10/11
    PubMedGoogle Scholar
  • 2 Fulzele K, DiGirolamo DJ, Liu Z et al. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 2007; 282: 25649-25658 Epub 2007/06/08
    CrossrefPubMedGoogle Scholar
  • 3 Pramojanee SN, Phimphilai M, Chattipakorn N et al. Possible roles of insulin signaling in osteoblasts. Endocr Res 2014; Epub 2014/04/01
    PubMedGoogle Scholar
  • 4 Fowlkes JL, Bunn RC, Thrailkill KM. Contributions of the Insulin/Insulin-Like Growth Factor-1 Axis to Diabetic Osteopathy. J Diabetes Metab 2011; 1 Epub 2011/11/25
    PubMedGoogle Scholar
  • 5 Liu HC, Zhao H, Chen J et al. Role of recombinant plasmid pEGFP-N1-IGF-1 transfection in alleviating osteoporosis in ovariectomized rats. J Mol Histol 2013; 44: 535-544 Epub 2013/03/20
    CrossrefPubMedGoogle Scholar
  • 6 Bu YH, He YL, Zhou HD et al. Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. J Endocrinol 2010; 206: 271-277 Epub 2010/06/08
    CrossrefPubMedGoogle Scholar
  • 7 Hie M, Iitsuka N, Otsuka T et al. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 2011; 28: 455-462 Epub 2011/05/14
    PubMedGoogle Scholar
  • 8 Katz S, Ayala V, Santillan G et al. Activation of the PI3K/Akt signaling pathway through P2Y(2) receptors by extracellular ATP is involved in osteoblastic cell proliferation. Arch Biochem Biophys 2011; 513: 144-152 Epub 2011/07/19
    CrossrefPubMedGoogle Scholar
  • 9 Wang Y, Li LZ, Zhang YL et al. LC, a novel estrone-rhein hybrid compound, promotes proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells. Mol Cell Endocrinol 2011; 344: 59-68 Epub 2011/07/20
    CrossrefPubMedGoogle Scholar
  • 10 Adinolfi E, Amoroso F, Giuliani AL. P2 x 7 Receptor Function in Bone-Related Cancer. J Osteoporos 2012; 2012: 637863 Epub 2012/09/13
    PubMedGoogle Scholar
  • 11 Wang Y, Wang WL, Xie WL et al. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation. Phytomedicine 2013; 20: 787-796 Epub 2013/05/04
    CrossrefPubMedGoogle Scholar
  • 12 Gu YX, Du J, Si MS et al. The roles of PI3K/Akt signaling pathway in regulating MC3T3-E1 preosteoblast proliferation and differentiation on SLA and SLActive titanium surfaces. J Biomed Mater Res A 2013; 101: 748-754 Epub 2012/09/04
    PubMedGoogle Scholar
  • 13 Krum SA, Chang J, Miranda-Carboni G et al. Novel functions for NFkappaB: inhibition of bone formation. Nat Rev Rheumatol 2010; 6: 607-611 Epub 2010/08/13
    CrossrefPubMedGoogle Scholar
  • 14 Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115-137 Epub 2000/04/27
    PubMedGoogle Scholar
  • 15 Liu LJ, Liu LQ, Bo T et al. Puerarin Suppress Apoptosis of Human Osteoblasts via ERK Signaling Pathway. Int J Endocrinol 2013; 2013: 786574 Epub 2013/07/12
    PubMedGoogle Scholar
  • 16 Jilka RL, O’Brien CA, Roberson PK et al. Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age. J Bone Miner Res 2014; 29: 103-117
    CrossrefPubMedGoogle Scholar
  • 17 Coe LM, Lippner D, Perez GI et al. Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity. J Cell Biochem 2011; 112: 2403-2411 Epub 2011/05/04
    CrossrefPubMedGoogle Scholar
  • 18 Walker RJ, Anderson NM, Bahouth S et al. Silencing of insulin receptor substrate-1 increases cell death in retinal Muller cells. Mol Vis 2012; 18: 271-279 Epub 2012/02/14
    PubMedGoogle Scholar
  • 19 Posadas I, Santos P, Cena V. Acetaminophen induces human neuroblastoma cell death through NFKB activation. PLoS One 2012; 7: e50160 Epub 2012/11/21
    CrossrefPubMedGoogle Scholar
  • 20 Ueno H, Kondo E, Yamamoto-Honda R et al. Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function. Mol Biol Cell 2000; 11: 735-746 Epub 2000/02/26
    CrossrefPubMedGoogle Scholar
  • 21 Hu J, Qi MC, Zou SJ et al. Construction of recombinant plasmid pEGFP-BMP7 and its expression in rat bone marrow mesenchymal stem cells in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi 2005; 23: 463-466
    PubMedGoogle Scholar
  • 22 Han N, Zhang DY, Wang TB et al. Calcitonin gene-related peptide induces proliferation and monocyte chemoattractant protein-1 expression via extracellular signal-regulated kinase activation in rat osteoblasts. Chin Med J (Engl) 2010; 123: 1748-1753 Epub 2010/09/08
    PubMedGoogle Scholar
  • 23 Sliwinski L, Folwarczna J, Nowinska B et al. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system. Acta Biochim Pol 2009; 56: 261-270 Epub 2009/04/30
    PubMedGoogle Scholar
  • 24 Wang B, Bi M, Zhu Z et al. Effects of the antihypertensive drug benidipine on osteoblast function. Exp Ther Med 2014; 7: 649-653 Epub 2014/02/13
    PubMedGoogle Scholar
  • 25 Wang XF, Xie Y, Wang HG et al. alpha-Tocopheryl succinate induces apoptosis in erbB2-expressing breast cancer cell via NF-kappaB pathway. Acta Pharmacol Sin 2010; 31: 1604-1610 Epub 2010/12/04
    CrossrefPubMedGoogle Scholar
  • 26 Li B, Wang Y, Liu Y et al. Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model. Endocrine 2013; 43: 136-146 Epub 2012/07/24
    CrossrefPubMedGoogle Scholar
  • 27 DeMambro VE, Kawai M, Clemens TL et al. A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. J Endocrinol 2010; 204: 241-253 Epub 2009/12/25
    CrossrefPubMedGoogle Scholar
  • 28 Granero-Molto F, Myers TJ, Weis JA et al. Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects. Stem Cells 2011; 29: 1537-1548 Epub 2011/07/26
    CrossrefPubMedGoogle Scholar
  • 29 Viallet PM, Vo-Dinh T. Monitoring intracellular proteins using fluorescence techniques: from protein synthesis and localization to activity. Curr Protein Pept Sci 2003; 4: 375-388
    CrossrefPubMedGoogle Scholar
  • 30 McGonnell IM, Grigoriadis AE, Lam EW et al. A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?. Front Endocrinol (Lausanne) 2012; 88 Epub 2012/07/27
    PubMedGoogle Scholar
  • 31 Kim DY, Jung SY, Kim CJ et al. Treadmill exercise ameliorates apoptotic cell death in the retinas of diabetic rats. Mol Med Rep 2013; 7: 1745-1750
    CrossrefPubMedGoogle Scholar